SCHD vs TRDA
SCHD (SCHD) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
SCHD (SCHD) common stock.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
SCHD does not have a complete income-statement cache yet.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
SCHD currently screens at market cap $0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the SCHD and TRDA stock pages for the full models.
Not investment advice.